Image default
Water News

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses

Times Now | 03 Jun 2021, 11:39 AM IST

The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine after Bharat Biotech’s COVAXIN. Biological-E’s COVID-19 vaccine, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 clinical trials.



Related posts

Decks cleared for import of Bharat Biotech’s Covaxin, Russia’s Sputnik V into Brazil


Tears, prayers, police, JCB: How Saroj Hospital saved over 100 lives


Delhi’s LNJP hospital, left with just 2 hours of oxygen supply, receives refill


Leave a Comment